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ABSTRACT
Despite the great strides made in the treatment of cancer, considerably little
progress has been made towards prevention of the disease. In light of this reality, it has
become apparent that a greater focus needs to be devoted to research into means of
cancer prevention. Due to the significant role that nutrition plays in the development of
cancer, the diet presents an attractive and logical target for such research.
Epidemiology has consistently shown an inverse relationship between fruit and
vegetable consumption and risk for developing cancer. Additionally, countless in vitro
studies on natural products isolated from fruits and vegetables have revealed many
properties that could contribute to an anticancer effect. While many epidemiological
observations have been made and many in vitro assays have been performed, very little
work has been conducted to investigate the actual physiological effect(s) that result from
consumption of fruits and vegetables. This study was undertaken in an attempt to begin
to address this issue.
The goal of the present study was to evaluate the in vitro anticarcinogenic
properties of red raspberry extract and determine the effect of red raspberry consumption
on the levels of cytotoxicity exerted by Natural Killer (NK) cells.
Fifteen volunteers participated in the portion of the study evaluating cytotoxic
activity of NK cells. Five of the 15 volunteers showed a significant increase in cytotoxic
activity levels of NK cells following consumption of red raspberries. Additionally,
plasma taken from three individuals following red raspberry consumption showed a
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significantly higher antiproliferative effect on MCF-7 human breast cancer cells than
plasma taken prior to consumption of red raspberries.
When tested in vitro, red raspberry extract demonstrated a significant
antiproliferative effect on AGS human stomach cancer and LoVo human colon cancer
cell lines. Further testing revealed that pH was not a factor and that the antiproliferative
effect could not be attributed solely to antioxidant activity.
Although one of the first studies of its kind, this study provides a glimpse into the
downstream physiological effects that result from red raspberry consumption which could
contribute to the prevention of cancer. Our results suggest that consumption of red
raspberries has the potential to increase the cytotoxic activity of NK cells in some
individuals and may also lead to the accumulation of compounds in the plasma which can
exert an antiproliferative effect on transformed cells.
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1. LITERATURE REVIEW
For 2009 it was estimated that there would be more than 1.4 million new cases of
cancer diagnosed in the United States, with 562,340 expected to die from the disease
(American Cancer Society, 2009). The latest worldwide statistics, available for 2007,
estimated greater than 12 million new cases of cancer and 7.6 million deaths. It is
expected that by 2050 these numbers will swell to 27 million and 17.5 million,
respectively (American Cancer Society, 2007). In the United States, the total estimated
cost of cancer in 2008 was $228.1 billion (direct medical costs, indirect morbidity costs,
indirect mortality costs). Although survival rates for most cancers have risen steadily,
from 50% for cancers diagnosed between 1975-1977 to 60% for cancers diagnosed
between 1996-2003, there has been comparatively little progress made towards
prevention (American Cancer Society, 2009). While research into treatments for cancer
remains a necessity, it is imperative that there be an increased focus on prevention.
Diet and Cancer
According to the American Cancer Society (2009), approximately one-third of
cancer deaths in the United States each year can be attributed to nutrition and lifestyle.
Worldwide, diet and nutrition are implicated in 50% of all cancers (American Cancer
Society, 2007). In light of these statistics, the diet presents a very attractive, logical and
necessary target for research into cancer prevention.
Epidemiological evidence has shown an inverse relationship between fruit and
vegetable consumption and risk for developing cancer (Doll, 1990). These results are in
keeping with the now widely accepted fact that fruits and vegetables contain a vast array
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of bioactive phytochemicals, many of which have shown anticarcinogenic potential in in
vitro assays. However, progress in this area has been slowed as conflicting reports have
been received from different epidemiological studies. While some studies show an
inverse relationship between fruit and vegetable consumption and risk for developing
cancer, others show no effect and some have shown an increase in cancer risk (Willett,
2008).
Consequently, many researchers have shifted their focus to evaluating the
individual components of fruits and vegetables for various anticarcinogenic properties.
In vitro results from these studies have identified a seemingly endless list of bioactive
components that have some anticarcinogenic potential (Pan and Ho, 2008).
While it is generally believed that the same mechanisms which produce the in
vitro results are responsible for generating the observed epidemiological results, there is a
dearth of literature demonstrating the positive physiological changes that result from the
consumption of fruit and vegetable products. Due to the extreme complexities of
metabolism and the composition of fruits and vegetables, it is certain that the metabolic
products of consumed fruits and vegetables will vary considerably from the compounds
that are tested in an in vitro setting. Consequently, a greater focus needs to be given to
examining the physiological changes resulting from consumption of fruits and
vegetables. The aim of this study was to evaluate the anticarcinogenic potential of red
raspberry extract, particularly its ability to stimulate increased cytotoxic activity of
natural killer (NK) cells.
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Natural Killer Cells
General Biology
NK cells were first described in the early 1970s and were recognized for their
ability to lyse tumor cells without prior sensitization. Several groups, including
Herberman et al. (1975) and Kiessling et al. (1975a, 1975b), demonstrated that mouse
Moloney leukemia cells were highly sensitive to killing by these lymphocytes from
nonimmunized donors. Because of their ability to induce cytotoxicity in target cells
without prior sensitization, it was assumed that killing was the default mechanism for
these cells and, in the absence of an inhibitory signal, any target cell would be killed.
Thus, these lymphocytes were termed “’natural’ killer cells”. Self MHC class I was
hypothesized to be the inhibitory signal and this led to the development of the “missing
self” hypothesis. Although their name has remained unchanged, thirty years of research
has revealed that these cells are far more complex than originally thought. It is now wellestablished that NK cells have a vast repertoire of both inhibitory and stimulatory
receptors, and the balance of signal delivered by the target cell determines its fate. While
NK cells certainly live up their name by inducing cell death in appropriate targets, they
are also key producers of various cytokines, principally IFN-γ.
Natural killer cells do not undergo gene rearrangement, and are thus considered
part of innate immunity. They are derived from CD34+ hematopoietic stem cells,
undergo maturation in the bone marrow and generally constitute 5-15% of the peripheral
blood lymphocytes (Miller et al., 1992). Natural killer cells are classified as CD3-CD56+
lymphocytes, and within this population there are two distinct subgroups which vary in

3

activity. CD56bright NK cells are primarily involved in cytokine production while
CD56dim NK cells are primarily cytotoxic (Ljunggren and Malmberg, 2007). The
primary functions of NK cells involve destruction of virus infected or transformed cells,
production of cytokines and antibody dependent cell-mediated cytotoxicity.
Adhesion to Target Cell
Upon making initial contact with a target cell, the NK cell must be tethered to the
target in order to allow inhibitory and stimulatory receptors the opportunity to make
contact with their ligands. The interactions that take place to initially tether the NK cell
to the target cell also function to stabilize the connection between the two cells, leading to
the formation of an immune synapse. One of the principal NK cell receptors involved in
this process is lymphocyte functional antigen-1 (LFA-1) (Barber et al., 2004; Bryceson et
al., 2005; Helander and Timonen, 1998; Osman et al., 2007). LFA-1 was first identified
as an adhesion receptor on T-cells, but has since been shown to be vital for NK cell
function as well (Giblin and Lemieux, 2006). Intercellular adhesion molecule (ICAM)-1
through ICAM-5 expressed on target cells, serve as the ligands for LFA-1 (Bryceson et
al., 2005). Matsumoto et al. (2000) used LFA-1 -/- knockout mice to show that LFA-1 is
a necessary component for adhesion to take place between IL-12-activated NK cells and
their targets. Additionally, patients suffering from leukocyte adhesion disorder caused by
LFA-1 deficiency experience impaired immunity (Bunting et al., 2002) and antibodies
blocking LFA-1 inhibit cytotoxicity by preventing the NK cell from binding to its target
(Chen et al, 1987). In addition to its role in adhesion, several studies indicate that LFA-1
delivers an early activating signal which contributes to the polarization of the NK cell’s
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cytotoxic granules (Barber et al., 2004; Helander and Timonen, 1998; Osman et al.,
2007), as well as the phosphorylation of VAV1, a guanine nucleotide exchange factor,
which is involved in the signaling cascade that leads to activation of the NK cell (Riteau
et al., 2003). Thus LFA-1 has a dual role, functioning in both adhesion and activation.
Although LFA-1 is absolutely necessary for adhesion, it remains unclear if is main role is
this or in the delivery of an early activating signal.
Adhesion to the target cell is not complete following the initial binding of LFA-1
to ICAM-1. LFA-1 must undergo a further conformational change which leads to a highaffinity interaction with ICAM-1. This process is mediated by the cytoskeletal adaptor
protein, talin. Mace et al. (2009) demonstrated that talin is involved in two distinct
signaling processes related to LFA-1 interactions. First, upon initial binding of LFA-1 to
ICAM-1, talin is activated and delivers an inside-out signal by separating the two
cytoplasmic tails of LFA-1 which causes it to switch to its high-affinity conformation
(Kim et al., 2003). As evidence for this, Mace et al. (2009) showed that talin knockout
NK cells were unable to bind to ICAM-1. Second, following the change of LFA-1 to its
high affinity conformation, talin is involved in outside-in signaling that leads to
reorganization of the actin cytoskeleton, a process required for polarization of the NK
cell’s cytotoxic granules and microtubule organizing center (MTOC) (Mace et al., 2009).
Stimulating Receptors and Activation
Having been attached to its target through the LFA-1-mediated processes
described above, the NK cell now integrates signals being delivered from its various
activating and inhibitory receptors. Upon binding to a target cell it is likely that both
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inhibitory and stimulatory receptors will be engaged at the immune synapse, and the
action of the NK cell is determined by the balance of signal received from these
receptors. It appears that no single activating receptor is capable of fully activating a NK
cell. Rather, NK cell activation depends on a combination of activating signals that are
capable of crossing a critical threshold allowing them to overcome signals being
delivered by inhibitory receptors. Work by Bryceson et al. (2006b) suggests that NK
stimulatory receptors work in a synergistic or additive manner in order to generate
sufficient signal to overcome inhibition. This strategy for activation is contrasted by T
and B cells, which use a single antigen receptor along with various costimulatory
molecules for their activation. However, this approach makes sense given the NK cell’s
need to recognize a wide variety of ligands without prior sensitization.
A thorough review of NK receptors and signaling pathways can be found in
Bryceson et al. (2006a) and Lanier et al. (2008). Here we will discuss the general
signaling mechanisms employed by the various classes of receptors that lead to effector
function. The relevance of specific receptors as they relate to cancer will be discussed in
the following section.
One of the main signaling mechanisms employed by NK cells involves the use of
immunoreceptor tyrosine-based activation motif (ITAM) molecules. A large number of
NK stimulatory receptors associate with ITAM molecules to propogate their signal.
Among the receptors that use this mechanism are: natural cytotoxicity receptors (NKp30,
NKp44, NKp46), killer cell immunoglobulin-like receptor (KIR) family and CD16
(Bryceson et al., 2006b; Moretta et al. 2001). The ITAM molecules that function in
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signaling are CD3ζ, FCεRIγ and DAP12, and these are constitutively expressed on all
mature NK cells. ITAM-associated receptors will associate with a homodimer of
DAP12, or a homodimer or heterodimer of CD3ζ and FCεRIγ. For each receptor the
ITAM-associated proteins are always the same.
Upon receptor/ ligand binding, the receptor-associated ITAM proteins become
phosphorylated by members of the Src family kinases (Lck Fyn, Lyn), and subsequent
signaling events are very similar to those found in the B- and T-cell pathways. Once
phosphorylated, ITAMs serve as binding sites for protein tyrosine kinases Syk and ζassociated protein of 70 kDa (ZAP70) (Lanier, 2008). These molecules then trigger a
signaling pathway that leads to the release of calcium from the endoplasmic reticulum,
and this rise in cytoplasmic calcium results in activation of nuclear factor of activated T
cells (NF-AT) and NFκB (with the aid of diacylglycerol [DAG]). NF-AT and NFκB are
involved in transcriptional regulation which leads to cytokine production. Activation of
other pathway intermediates through ITAMs leads to reorganization of the actin
cytoskeleton and release of cytotoxic granules (Lanier, 2008). While signaling through
the ITAMs is capable of generating cytokine production or cytotoxicity, it appears that
the cytokine response is the stronger of the two.
Aside from the ITAM-associated receptors, another key NK stimulatory receptor
is NKG2D, which signals through the associated protein, DAP10. Upon binding of
NKG2D to its ligand, DAP10 becomes phosporylated and recruits phosphatidylinositol3-OH-kinase (PI3K) or a Grb2-Vav1-SOS1 signaling complex (Lanier, 2008; Lanier,
2009). It has recently been suggested that DAP10 couples with the IL-15 receptor and
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that IL-15 activates Janus kinase 3 (Jak3), which then phosphorylates DAP10 (Horng et
al., 2007). DAP10 signaling appears to induce primarily a cytotoxic response and seems
to be important in costimulation of activating signals from other receptors (Lanier, 2009).
Among the other activating receptors expressed on NK cells are various integrins,
members of the signaling lymphocyte activating molecule (SLAM) family (CD244,
CRACC, NTB-A), and DNAM-1. SLAM receptors signal by their own cytoplasmic tails,
appear capable of delivering activating or inhibitory signals and function as coreceptors
that require simultaneous engagement of the natural cytotoxicity receptors (Bottino et al.,
2003; Veillette, 2006). DNAM-1 activity is dependent on LFA-1 expression and its
function is deficient in patients with leukocyte adhesion deficiency syndrome (Veillette
and Latour 2003).
While a detailed review of all NK stimulatory receptors is not possible here, it
should be readily apparent that NK-induced cytotoxicity is far more complex than
originally thought. Additionally, it should be appreciated that NK cells express a vast
array of receptors that are capable of recognizing many ligands that would be found on
transformed cells or virus infected cells.
Effector Functions
Once activated, the NK cell will induce cytotoxicity in its target or will be
stimulated to produce cytokines. NK cells induce cytotoxicity in target cells in a virtually
identical manner to that of CD8+ T cells. Three mechanisms are employed by NK cells
to induce cytotoxicity: 1) Release of perforin/granzyme cytotoxic granules; 2) Fas/FasL;
3) TRAIL.
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The release of cytotoxic granules containing perforin and granzyme is highly
dependent on reorganization of the actin cytoskeleton that takes place following ligand
engagement by LFA-1. Rearrangement of the actin cytoskeleton allows for polarization
of the NK cell’s cytotoxic granules, and this process ensures that the granules will only
be released into the immune synapse of the target cell, thereby preventing damage to
surrounding cells. Perforin and granzyme are stored in preformed granules within the
NK cell, and this is key to their ability to mount a rapid cytotoxic response to target cells.
While LFA-1 is capable of delivering sufficient signal to trigger reorganization of the
actin cytoskeleton, additional activating signals are required in order to initiate granule
polarization and degranulation.
Once a sufficient number of activating signals have been delivered, the cytotoxic
granules need to be delivered to the immune synapse. The microtubule organizing center
(MTOC) is a central player in this process as cytotoxic granules move along microtubules
and assemble at the MTOC (Orange, 2008). With cytotoxic granules now organized
around it, the MTOC must polarize to the immune synapse in order to deliver the
granules for degranulation. It is unclear exactly what processes take place to move the
MTOC to the immune synapse, but Chen et al. (2006; 2007) have shown that
phosphorylation of ERK2 (a downstream signaling molecule in the activating signaling
cascade) is required for MTOC polarization. Once the MTOC has arrived at the immune
synapse, small channels are formed in the actin network to allow passage of the relatively
large cytotoxic granules (Orange, 2008).
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Following degranulation, perforin and granzyme are taken in by the target cell
and apoptosis is induced by activation of the caspase cascade. While it has been
conclusively demonstrated that both perforin and granzyme are necessary for induction of
apoptosis, the exact mechanisms by which they interact with one another to mediate this
process is currently undetermined. It was originally proposed that perforin formed pores
in the target cell membrane and granzyme simply passed through these pores. However,
evidence has accumulated that indicates this is likely not the case. First, it has been
questioned whether pores formed by perforin would be large enough to allow passage of
the relatively large granzyme molecules. Second, several studies have demonstrated that
granzyme can be found localized in endosomes in target cells even in the absence of
perforin. Thus, it would seem that perforin is neither capable of, nor necessary for,
allowing perforin to enter target cells. Based on accumulated evidence, Pipkin and
Liberman (2007) hypothesize that perforin and granzyme are co-endocytosed and that
perforin perturbs the endosomal membrane, mediating release of granzyme.
Two granzymes are released by NK cells: granzyme A and granzyme B.
Granzyme B is the better characterized of the two and is known to induce both caspasedependent cell death and caspase-independent cell death. Granzyme B is known to
directly cleave pro-caspase-3, however this seems insufficient for full activation of procaspase-3. Additional activation is achieved by the granzyme B-mediated cleavage of
Bid. Bid then migrates to the mitochondria and recruits Bax and Bak, which oligomerize
in the mitochondrial membrane and mediate the release of various proteins including
Smac/Diablo, HtrA2/Omi and cytochrome c. Smac/Diablo and HtrA2 then remove
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inhibitor of apoptosis proteins (IAPs) from caspase-3 to complete its activation. Caspase3 is an effector caspase that cleaves inhibitor of caspase-activated DNA (ICAD)
mediating the release of CAD, which migrates to the nucleus and initiates fragmentation
of the DNA (Wowk and Trapani, 2004; Cullen and Martin, 2008).
An alternative method of caspase-dependent cell death mediated by granzyme B
involves the release of the cytochrome c from the mitochondria, mentioned above.
Cytochrome c assembles with apoptotic protease-activating factor 1 (APAF-1) and procaspase-9. This results in the activation of caspase-9 (an activating caspase) which then
cleaves and activates other caspases leading to fragmentation of the DNA (Cullen and
Martin, 2008). The caspase-independent mechanism of cell death mediated by granzyme
B is likely the result of mitochondrial permeabilization and a resultant decrease in ATP
production (Cullen and Martin, 2008).
Granzyme A is also released by NK cells, and is involved only in caspaseindependent cell death. Upon its release into the cell, granzyme A migrates to the
nucleus and targets the SET complex. This is a complex of three granzyme A substrates
(SET, HMGB2, and APE1) as well as pp32 and NM23-H1. In the nucleus granzyme A
cleaves and inactivates SET, which is an inhibitor of the DNase NM23-H1. NH23-H1
then proceeds to initiate single-stranded DNA nicks. Another potential component of this
pathway is the 3’-5’ exonuclease, TREX1. It is speculated that TREX1 is released upon
degradation of the SET complex and prevents DNA repair by removing bases from the
free 3’ end (Cullen and Martin, 2008).
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While perforin/granzyme is the principal mechanism by which NK cells elicit
their cytotoxic results on target cells, in a more limited fashion they also employ the use
of TNF-related apoptosis-inducing ligand (TRAIL) and FasL (known as “death
receptors”). The pathways work in a similar fashion and involve the use of caspases,
bearing some similarities to the granzyme B pathway. Both receptors are upregulated
following stimulation with cytokines or by activating receptors. When Fas (located on
the target cell) binds to FasL, Fas-associated death domain (FADD) and pro-caspase-8
are recruited to its cytoplasmic domain, forming a death-inducing signaling complex
(DISC). At the DISC, pro-caspase-8 is auto-processed and caspase-8 is then capable of
activating pro-caspase-3 and Bid. Subsequent activities for caspase-3 and Bid are the
same as discussed above for the granzyme B pathway (Zamai et al., 1998; Screpanti et
al., 2005).
TRAIL functions in a nearly identical manner to FasL. TRAIL receptors
expressed on target cells are TRAIL-R1 or TRAIL-R2. Upon binding to TRAIL, procaspase-8 and TRAIL-associated death domain (TRADD) are recruited to the
cytoplasmic tails of the receptors. Ensuing steps are the same as for FasL (Zamai et al.,
1998; Screpanti et al., 2005).
Having seen how NK cells elicit one arm of their effector function by inducing
cytolysis in target cells, we now turn our focus to their production of cytokines. While
NK cells produce a number of different cytokines (GM-CSF, TNF-α, IL-10, IL-13), IFNγ is produced in the greatest quantities and is widely considered to be the prototypical NK
cytokine. As mentioned earlier, there are two subsets of NK cells and the CD56bright
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subset is largely responsible for IFN-γ production. IFN-γ is a potent cytokine and helps
to shape the TH1 immune response (Mocikat et al., 2003), stimulate macrophage killing
of intracellular pathogens (Filipe-Santos et al., 2006), activate upregulation of MHC class
I expression in APCs (Wallach et al., 1982), and exert antiproliferative effects on
transformed and virus infected cells. In light of these functions, it is not surprising that
this subset of NK cells is found primarily located in the parafollicular region of secondary
lymphoid tissue, where it can exert its effects on T cells and APCs (Fehniger et al., 2003;
Caligiuri, 2008). Because of their involvement in the above activities, NK cells form an
important link between the innate and adaptive immune response.
Inhibition
In comparison to activation, inhibition of NK cells is a relatively straightforward
process, acting essentially as an antagonist to stimulatory signaling. While NK
stimulatory receptors have several different signaling motifs and strategies, all inhibitory
receptors are members of the immunoreceptor tyrosine-based inhibition motif (ITIM)
family.
There are several different classes of inhibitory receptors, including the KIR
family. The inhibitory KIRs are distinguished from the stimulatory KIRs by the length of
their cytoplasmic tail. In the case of the stimulatory KIR, the cytoplasmic tails are short,
while those in the inhibitory KIRs are long. All of the inhibitory KIRs recognize HLA as
their ligands, as does the CD94/NKG2A inhibitory receptor. Another receptor type that
is not as well characterized is sialic acid-binding Ig-like lectin-7 (SIGLEC-7). This
receptor recognizes Sia on the target cell surface, and while mechanisms are poorly
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understood, it is assumed that this acts a “self” signal in much the same way as HLA
recognition (Yamaji et al., 2005).
Regardless of the receptor or ligand, it appears that in each case inhibition is
mediated by the same process. Ligation of the receptor to its ligand results in the
phosphorylation of the ITIM and SH2 domain-containing protein tyrosine phosphatase-1
(SHP-1) and SHP-2 are recruited. These two phosphatases then begin dephosphorylation
of signaling intermediates in the activation pathway. Two competing models exist to
explain the mode of action for SHP-1 and SHP-2. In the “promiscuous” model, these two
phosphatases act indiscriminately on various proteins in the activation pathway. In the
“selective” model, a few key intermediates are dephosphorylated resulting in abrogation
of the activation signal. Recent research seems to point to the selective model, with the
guanine nucleotide exchange factor Vav1, being the key target for SHP-1 and SHP-2.
Additionally, it has been demonstrated that SLP-76, ZAP-70 and Syk are also capable of
direct dephosphorylation by SHP-1 and SHP-2, but these seem to play a lesser role than
that of Vav1. The overall result of SHP-2 and SHP-2 activity is that the activation
signaling is abrogated and the necessary release of Ca2+ is prevented (Stebbins et al.,
2003; Long, 2008).
Natural Killer Cells and Cancer
Having already described the general strategies employed by NK cells to trigger
activation of effector functions, we can now look more closely at which receptors are
involved in the detection of transformed cells, the ligands they recognize and the
distribution of these ligands on transformed cells, the overall importance of NK cells to
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the prevention of cancer and how transformed cells are able to evade detection and
destruction by NK cells.
Receptors Involved in Detection of Transformed Cells
The primary receptors involved in the detection of transformed cells are the
natural cytotoxicity receptors (NCRs) and NKG2D. The NCRs include NKp46, NKp44
and NKp30. NKp46 and NKp30 are constitutively expressed on resting NK cells and
serve as the only specific NK markers, while NKp44 is only expressed following IL-2
activation (Arnon et al., 2006). NKp30 and NKp46 both signal through a homodimer or
heterodimer of FcεR1γ and CD3ζ while NKp44 signals through DAP-12. The
importance of the NCRs was shown in the studies that led to their discoveries,
demonstrating that monoclonal antibodies to the NCRs impaired NK-mediated killing of
many tumor cell lines (Arnon et al., 2006; Pende et al., 1999; Sivori et al., 1997; Sivori et
al., 1999; Pessino et al., 1998; Vitale et al, 1998)). NKp46 was the first of the NCRs to
be identified (Pessino et al, 1998; Sivori et al., 1999; Sivori et al., 1997) followed by
NKp44 (Vitale et al., 1998) and the only known ligand for each of these receptors is viral
hemagglutinin. NKp30 was discovered when work with blocking antibodies to NKp46
and NKp44 suggested there might be another NCR (Moretta et al., 2000). Unlike NKp44
and NKp46, there are no known ligands for NKp30. Though there are no known cellular
ligands for any of the NCRs, the evidence that blocking their activity results in the
impairment of NK cytotoxicity towards transformed cells highlights their importance in
NK function.
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NKG2D is another NK receptor known to be important for controlling the spread
of cancer (Smyth et al., 2005). Ligands for NKG2D are MHC class I chain related
antigens (MICA and MICB) and unique long 16-binding proteins (ULBPs). Expression
of each of these receptors is upregulated in response to cellular stress, such as DNA
damage, UV irradiation and heat shock (Gasser, et al., 2005; Groh et al., 1996). Further,
expression of MICA and MICB has been demonstrated on epithelial tumors, melanoma,
hepatic carcinoma and hematopoetic malignancies (Groh et al., 1999; Vetter et al., 2002;
Junushi et al., 2003; Salih et al., 2003). Rejection of tumors expressing ligands for
NKG2D has been shown to be dependent on functional NKG2D expression by CD8+ T
cells and NK cells (Waldhauer and Steinle, 2008).
Other receptors involved to a lesser extent in NK cell activation have been
defined as co-receptors and include 2B4, NTB-A and NKp80. The ligands for these
receptors are CD48, NTB-A and AICL, respectively (Moretta et al., 2005; Stark and
Watzl, 2006; Welte et al., 2006). While each of these receptors contributes to activation
of NK effector function, it appears that their activity requires co-ligation of the NCRs.
A final receptor involved in NK activation is DNAM-1. PVR and Nectin-2 have
been identified as ligands for DNAM-1 and these molecules are over-expressed on
several different tumor cell types. Moretta et al. (2005) showed that mAb blocking of
DNAM-1 inhibited NK cytotoxicity towards colon and ovarian carcinomas, K-562,
Jurkat and U937 cell lines, but not Epstein-Barr virus (EBV) B cell lines. Unlike the
susceptible targets, the EBV B cell lines generally do not express PVR or Nectin-2. Like
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2B4, NTB-A and NKp80, DNAM-1 activity requires co-ligation of the NCRs (Moretta et
al., 2005).
Natural Killer Cells in Cancer Prevention
It is quite clear that NK cells are very well equipped to perform their task of
identifying and eliminating transformed cells. But to what extent are they actually
involved in this process? Several pieces of compelling evidence point to an integral role
for NK cells in the prevention of cancer. Some of this evidence has emerged from
studies involving cancer patients, while research using murine models provides additional
support.
A murine study by Kim et al. (2000) demonstrated a critical role for NK cells in
the rejection of tumor cell lines. In this study, NK-deficient mice and wild type (WT)
mice were i.v. inoculated with the B16 cells or s.c inoculated with the RMA-S cell line,
murine T lymphoma deficient in MHC I. NK-deficient mice inoculated with the B16 cell
line showed >60-fold higher number of lung metastases than the WT mice receiving the
same treatment. When inoculated with the RMA-S cell line, NK-deficient mice failed to
reject as few as 100 RMA-S cells, while WT mice showed no tumor development over a
40 day interval. Wild type mice required nearly 100-fold more tumor cells to produce
similar tumor incidence.
In another murine study by Yang et al. (2003) adoptively transferred IL-2
activated NK cells were capable of reducing or eliminating well-established lung
metastases. This study revealed that NK cells are not only capable of preventing the
establishment of tumors, but have the ability to act on established tumors as well.
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Several lines of evidence exist from human studies as well. First, Imai et al.
(2000) performed an 11-year prospective cohort study correlating the levels of cytotoxic
activity in peripheral-blood lymphocytes to risk for developing cancer. The results of
their study showed that lower levels of peripheral-blood cytotoxic activity correlated with
an increased risk for cancer. Additionally, several studies have correlated the infiltration
of NK cells into tumors with a positive prognosis. This effect has been observed for
colorectal, gastric, lung and esophageal carcinomas (Coca et al., 1997; Ishigami et al.,
2000; Villegas et al., 2002; Hsia et al., 2005).
Transformed Cell Evasion Natural Killer Cell Destruction
In spite of the remarkable design of NK cells, which allows them recognize a
large number of markers on transformed cells and mount a rapid cytotoxic or cytokine
response, a variety of strategies are employed by tumors allowing them to evade
detection and/or destruction.
It appears that one of the key targets for evasion of NK detection and/or
destruction is NKG2D, and this underscores the importance of this receptor to NK
function. Tumor cells use at least two different strategies to negate the function of
NKG2D. The first strategy employed involves the shedding of soluble NKG2D ligands.
Recall that the ligands for NKG2D are MICA, MICB and ULBP. Several groups have
reported observations of different tumor cells shedding these molecules and releasing
them in a soluble form (Salih et al., 2002; Wu et al., 2004; Holdenrieder et al., 2006;
Waldhauer and Steinle, 2006). This has two effects on NKG2D-mediated detection. The
first, and most obvious effect, is that by shedding the ligands for NKG2D, the target cell
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reduces surface levels of the ligands, thereby minimizing the chances of NKG2D
detection. Secondly, the study by Wu et al. (2004) revealed that soluble forms of MICA
down-regulate NKG2D expression, and elevated levels of soluble MICA in sera correlate
with decreased NKG2D expression (Waldhauer and Steinle, 2008).
Another approach used by transformed cells to interfere with NKG2D function is
production of transforming growth factor β1 (TGF-β1). TGF-β1 is a powerful
immunosuppressive cytokine secreted by some tumors and can cause the down-regulation
of NKG2D as well as its ligands (Castriconi et al., 2003; Lee et al., 2004; Eisele et al.,
2006; Waldhauer and Steinle, 2008).
Some leukemia cell lines are capable of up-regulating expression of MHC I,
which would result in stronger inhibitory signals being delivered to the NK cells (Classen
et al., 2003). Acute myeloid leukemia patients frequently have decreased expression of
NCRs (Costello et al., 2002). Finally, tumors may increase expression of HLA-G which
binds to the KIR2DL4 inhibtory receptor on NK cells (Rouas-Freiss, 2005; Waldhauer
and Steinle, 2008).
It is altogether likely that various other mechanisms exist whereby potential
targets are able to inhibit the action of NK cells, resulting in their own survival and
potential progression to a solid tumor. It is apparent that the elimination of transformed
cells by NK cells is a delicate balancing act. Natural killer cells are equipped with an
arsenal of activating receptors, capable of triggering potent cytolytic activity, while
potential targets may attempt to overcome NK activation by delivering false inhibitory

19

signals to the NK cell. Any interventions that have the capacity to shift the balance
towards the NK cell could prove beneficial for the prevention of cancer.
In this study, we sought to take an initial step in bridging the gap between results
observed in epidemiological studies and results observed in in vitro settings. We chose to
evaluate the effect of red raspberry consumption on the in vitro activity of NK cells
against target K-562 cells. Fifteen volunteers were asked to consume freeze-dried red
raspberries for 4 days, with blood being drawn prior to beginning the study (pre blood
draw) and immediately after consumption of the berries on the 4th day (post blood draw).
Peripheral blood lymphocytes were isolated from each sample and evaluated for
cytotoxicity towards K-562 cells. Results from this portion of the study were somewhat
inconclusive, with 5 out of 15 volunteers showing a positive effect, others showing no
effect and some showing a negative effect.
Additionally, plasma samples from 3 volunteers were evaluated for their effect on
the growth of MCF-7 breast cancer cells. Growth medium supplemented with 10%
plasma from the volunteers’ post-consumption blood draw showed a strong inhibitory
effect when compared to growth medium supplemented with 10% plasma from the
volunteers’ pre blood draw or 10% FBS.
In an attempt to determine if extract from the freeze-dried red raspberries had any
direct effect on cancer cells lines, LoVo (colon), MCF-7 (breast) and AGS (stomach) cell
lines were treated with a 10% red raspberry extract solution. Viability for each cell line
was reduced nearly 100%. However, the mechanism of cell death being induced proved
elusive. Microscopic observations showed the cells to be intact following treatment,
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seemingly eliminating necrosis. The AGS cell line was evaluated for activation of
caspases 3/7, 8 and 9, but showed no increase in activity when treated cells were
compared to untreated cells. Treated and untreated AGS cells were then prepared for
confocal microscopy by staining with DAPI (for double-stranded DNA) and Texas
Red®-X phalloidin (for F-actin).
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2. MATERIALS AND METHODS
Human Subjects
Fifteen participants were recruited on a volunteer basis and required to consume 2
servings of freeze-dried red raspberries each day for 3 days and 1 serving for breakfast on
Day 4 (7 servings total; 1 serving = 22 g). Prior to beginning the study, each participant
read and signed an informed consent form and filled out a questionnaire providing
information on his/her usual diet and frequency of exercise. Starting three days prior to
beginning the study, participants were asked not to consume any fruits, vegetables,
products containing fruits or vegetables, or alcoholic beverages. This diet was
maintained for the duration of each subject’s participation. Following the final blood
draw on Day 4, each individual was compensated with $40 for his/her participation.
On Day 1 of the study, 30 ml of the participant’s blood was obtained using 10 ml
Vacutainer® tubes containing sodium heparin. All blood draws were performed by
certified medical technologists in the Redfern Health Center, located on the campus of
Clemson University. At the time of the blood draw, the participant was given the berries
and asked to consume them as explained above.
Natural Killer Cell Cytotoxicity Assay
To assay the participant for NK cytotoxicity following berry consumption, blood
was drawn approximately 4-5 hrs following consumption of the last serving of berries.
The blood was processed and the NK cytotoxicity was determined as described below.
For each donor, the blood mononuclear cells were isolated using Histopaque-1077
®. Briefly, 15 ml of blood was layered on 15 ml of Histopaque-1077® in a 50 ml conical
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centrifuge tube. The tubes were centrifuged for 30 minutes at 400 x G in a swinging
bucket rotor with no brake. Following this centrifugation, the top plasma layer was
aspirated off into separate tubes and stored at -80°C. The buffy coat layer, containing
mononuclear cells, from each tube was aspirated off and added to 10 ml of phosphate
buffered saline (PBS). These tubes were gently vortexed and centrifuged at 250 x G for
10 minutes in a swinging bucket rotor. The supernatant was discarded, the cell pellet
resuspended in 5 ml of PBS, and the tubes centrifuged at 250 x G for 10 minutes. This
step was repeated for one more washing and centrifugation. The final cell pellet in each
tube was resuspended in 0.5 ml of PBS and the resulting suspensions were combined.
The washed mononuclear cells were counted and adjusted to 1 x 107 cells/ml.
This preparation of cells was then used in magnetic bead depletion of
monocytes/macrophages using Dynabeads® CD14 (Invitrogen™). The protocol
provided with the beads was followed to achieve depletion of the
monocytes/macrophages. The cells remaining after this treatment were peripheral blood
lymphocytes (PBL) and were used as effector cells in the NK cytotoxicity assay. Natural
killer cells should comprise 5-15% of the PBL. Chronic myelogenous leukemia K-562
cells were used as the target cells in the NK cytotoxicity assay. K-562 cells lack MHC
expression and have become the standard cell line for evaluating NK cytotoxicity. K-562
cells were maintained in Iscove’s Modified Dulbecco’s Medium, supplemented with 10%
FBS.
Target cells were plated in a 96 well plate at 5 x 103 cells/well in 50 µl total
volume. The cells remaining after monocyte/macrophage depletion were used as effector
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cells in the assay. The cells were counted and added to the target cells in the following
ratios (effector:target): 20:1, 10:1, 5:1, 2.5:1, 1.25:1. For each ratio 50 µl of effectors
were added to the appropriate wells. Each ratio was assayed in quintuplicate. In later
NK assays, the 1.25:1 and 2.5:1 ratios were discontinued and replaced with 15:1 and
7.5:1. The following wells were prepared in each assay: blank (media only), target only
(T), effector only (E), effector + target (ET). Following the addition of the effector cells,
the plate was centrifuged in a swinging bucket rotor at 65 x G for 5 min and then
incubated for 4 hrs at 37°C. Viability was measured using the CellTiter 96® cell
proliferation assay from Promega (Madison, WI). This kit measures cell viability using
the MTS tetrazolium salt and an electron coupling reagent (phenazine methosulfate).
Viable cells metabolize MTS into a formazan product that is readily soluble in tissue
culture medium. Following incubation, 20 µl of CellTiter 96® assay reagent was added
to each well. The plate was incubated for 4 h at 37°C and the absorbance read at 495 nm.
The calculation of cytotoxicity was performed as follows:
[( (T) – (ET – E) ) / T] x 100 = % cell death
Plasma Assays
In addition to NK cytotoxicity, the plasma from three participants was assayed for
its effect on the survival of MCF-7 human breast cancer cells. Plasma from participants
P01, P02 and P11 was used to prepare MCF-7 growth medium as follows: 1) 90%
DMEM, 10% FBS, 0% plasma; 2) 90% DMEM, 7% FBS, 3% plasma; 3) 90% DMEM,
5% FBS, 5% plasma; 4) 90%, 2% FBS, 8% plasma; 5) 90%, 0% FBS, 10% plasma; 6)
88% DMEM, 0% FBS, 12% plasma. For each participant, separate media were prepared
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using plasma from before and after raspberry consumption. The 10% FBS medium
served as the control. MCF-7 were plated at 2x104 cells/well in the appropriate medium
and incubated for 48 h at 37°C in 5% CO2. Following incubation, cell viability was
measured using the MTS assay as described above. Due to the loss of plasma activity
resulting from a freeze/thaw effect, replicates of this assay were not possible. For the
same reason, plasma samples from other participants were not assayed for this property.
Effect of Red Raspberry Extract on Cancer Cells in vitro
Using the MTS assay, red raspberry extract was assayed for its effect on the
survival of LoVo (colon), MCF-7 (breast) and ABS (stomach) cell lines. LoVo and AGS
cells were maintained in F-12K medium, supplemented with 10% FBS. Red raspberry
extract was prepared by blending 22 g of freeze dried berries with 200 ml of ddH2O. The
blended product was then centrifuged and the supernatant was collected and filter
sterilized through a .2 µm syringe filter. The filter sterilized extract was mixed with
sterile water to give concentrations of 20%, 15% and 10%.
Cells were plated in 50 µl of the appropriate complete medium at the following
densities: ABS) 2x104 cells/well; LoVo) 6.25x104 cells/well; MCF-7) 2.5x104
cells/well. These cell numbers for each cell line were optimized with earlier MTS assays.
50 µl of 0% (water only) 10%, 15% and 20% red raspberry extract were added to the
cells to give final extract concentrations of 0%, 5%, 7.5% and 10%. The following wells
were prepared in quintuplicate for each cell line: 1) Blank (DMEM for MCF-7; F-12K
for LoVo and ABS); 2) 0% extract plus cells; 3) 10% extract plus cells; 4) 15%
extract plus cells; 5) 20% extract plus cells. The plate was incubated for 48 h at 37°C in
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5% CO2. Following incubation the supernatant from each well was aspirated off and
replaced with fresh medium. Twenty µl of MTS was added to each well, the plate was
incubated for 4 h at 37°C in 5% CO2, and the absorbance at 490 nm was read.
The extract was also assayed for its effect on each of the above cell lines
following adhesion. To test this, the cells were plated as described above and incubated
for 24 h at 37°C in 5% CO2 to allow for adherence. Following this incubation, the cells
were treated with extract as described above and the remainder of the procedure was
carried out in an identical manner.
Separate assays were set up where each cell line was plated and treated with
extract as described above. Following 48 h of treatment, the culture medium was
aspirated off and the cells were treated with trypan blue to determine viability.
Caspase Activation in Cancer Cells Treated with Red Raspberry Extract
In order to determine the cause of decreased viability as measured in the assay
described above, activation of caspases was evaluated in cells treated with 10% red
raspberry extract. The activity of Caspases 3/7, 8 and 9 were measured in the AGS cell
line using the Caspasae-Glo® assay kit from Promega (Madison, WI). In this assay, cells
were plated as described above and treated with 10% extract for 1 hr. Following
treatment, the culture supernatant was aspirated off and 100 µl of Caspase-Glo® reagent
was added to each well. Following incubation at room temperature for 30 minutes, the
plate was read in a luminometer.
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Cell Viability When Treated with Red Raspberry Extract in the Presence of a
Caspase Inhibitor
Preliminary data obtained from the caspase inhibition assays suggested that
caspases were not being activated as a result of treatment with the raspberry extract. To
further explore the possible involvement of caspases, cell viability was measured in cells
treated with 10% red raspberry extract and a pan caspase inhibitor, Z-VAD-FMK
(carbobenzoxy-valyl-alanyl-aspartyl-[O-methyl]-fluoromethylketone). LoVo, AGS and
MCF-7 cells were used and were treated with 10% extract as described above in the
viability assays, but with the addition of 50 µM Z-VAD-FMK. Cells were incubated for
24 hr and viability was measured using the MTS assay.
Antioxidant Capacity
In order to determine the cytotoxic effect of the extract, the antioxidant capacities
of the extract and ascorbic acid were measured. Prior to each assay, fresh extract and
ascorbic acid solutions were prepared as used in the cell treatment assays described
above. Both solutions were tested at a 10% concentration according to the protocol for
the Total Antioxidant Status Assay Kit from Calbiochem®. The assay was performed in
triplicate, and in each assay the blank, standard, extract and ascorbic acid were measured
in triplicate. Absorbance was measured at 600 nm using a 37°C temperature controlled
spectrophotometer.
Confocal Microscopy
Each cell line was examined by confocal microscopy to observe any
morphological changes that occurred following treatment with raspberry extract. AGS
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cells were plated in the same densities as described above in 1 ml of complete culture
medium in 2 wells in a 6-well plate. Prior to the addition of the cells, a glass coverslip
was placed in each well. Following 24 hours of incubation in 5% CO2, 1 ml of 20%
raspberry extract solution (10% final concentration) was added to 1 of the wells and 1 ml
of sterile water was added to the other well. After 48 h of treatment, the culture
supernatant was aspirated off and discarded. Both coverlips were rinsed with 37°C PBS
and fixed with fresh 4% paraformaldehyde for 10 minutes at room temperature. After
fixation, each coverslip was rinsed 3x with PBS for 2 minutes for each wash. The cells
were then permeabilized by treatment with 0.2% Triton X-100 in PBS for 5 minutes.
Both coverlslips were rinsed 4x with PBS for 2 minutes for each wash and then stained
with DAPI and Texas Red®-X phalloidin (Molecular Probes™) according to the staining
protocols provided. Once stained, the coverslips were dehydrated with a graded ethanol
series for 10 minutes each as follows: 50%  70%  90%  95%  absolute. The
coverslips were then mounted on glass slides using Permount ®. When ready for
viewing, the slides were viewed using a Nikon ™ Eclipse Ti confocal microscope. DAPI
was excited with a 405 nm laser coupled with a 488 nm detector. Texas Red®-X
phalloidin was excited with a 543 nm laser coupled with a 605 nm detector.
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3. RESULTS
Fifteen volunteers were assayed for NK cell cytotoxic activity before and after
consumption of red raspberries. Five of the fifteen participants showed a significant
increase in NK cytotoxicity towards K-562 cells for at least one of the following effector
to target ratios: 5:1, 10:1 or 20:1. Due to high variability and lack of effect in the 1.25:1
and 2.5:1 ratios, these values were deemed unreliable and omitted. Ten of the fifteen
participants showed no effect or a negative effect (appendix). Results for the 5
individuals showing a significant increase in NK cytotoxicity are presented in Figure 1Figure 5. Of the 5 positive results, 3 participants (P002, P004, P009) had a significant
increase in NK cytotoxicity at the 20:1 ratio only. P008 displayed a significant increase
in NK cytotoxicity only at the 10:1 ratio while P006 showed significant increases at all
three ratios. A significant decrease in NK cytotoxicity was observed only at the 5:1 ratio
for P009.
In addition to NK cytotoxicity, preliminary assays were done to test for the
cytotoxic effect of three participants’ plasma on the growth of MCF-7 cells. Plasma used
in the assays was isolated from blood drawn before (pre) and after (post) consumption of
red raspberries by participants P01, P02 and P11, whose NK cytotoxicity levels were also
measured in the NK cytotoxicity assays. The results from these assays are shown in
Figure 6-Figure 8. Each of the participants assayed showed a significant increase at one
of the plasma concentrations when the cytotoxic effect of the post plasma was compared
to the cytotoxic effect pre plasma. P01 and P02 both showed a significant increase in
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Figure 1: Percent of K-562 target cells killed by treatment with peripheral blood lymphocytes (PBL)
isolated from P002 before and after consumption of red raspberries. K-562 and PBL were
incubated together for 4 h. This was followed by a measurement of cell viability using the MTS
assay. *, P < 0.05 for differences in percentage of cell death between pre (white bar) and post (black
bar) treatments.
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Figure 2: Percent of K-562 target cells killed by treatment with peripheral blood lymphocytes (PBL)
isolated from P004 before and after consumption of red raspberries. K-562 and PBL were
incubated together for 4 h. This was followed by a measurement of cell viability using the MTS
assay. *, P < 0.05 for differences in percentage of cell death between pre (white bar) and post (black
bar) treatments.
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Figure 3: Percent of K-562 target cells killed by treatment with peripheral blood lymphocytes (PBL)
isolated from P006 before and after consumption of red raspberries. K-562 and PBL were
incubated together for 4 h. This was followed by a measurement of cell viability using the MTS
assay. *, P < 0.05 for differences in percentage of cell death between pre (white bar) and post (black
bar) treatments.
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Figure 4: Percent of K-562 target cells killed by treatment with peripheral blood lymphocytes (PBL)
isolated from P008 before and after consumption of red raspberries. K-562 and PBL were
incubated together for 4 h. This was followed by a measurement of cell viability using the MTS
assay. *, P < 0.05 for differences in percentage of cell death between pre (white bar) and post (black
bar) treatments.

33

P009 NK Cytotoxicity
60

*
50

% Cell Death

40

*

30
Pre
Post

20

10

0
5:1

10:1

20:1

Effector:Target

Figure 5: Percent of K-562 target cells killed by treatment with peripheral blood lymphocytes (PBL)
isolated from P009 before and after consumption of red raspberries. K-562 and PBL were
incubated together for 4 h. This was followed by a measurement of cell viability using the MTS
assay. *, P < 0.05 for differences in percentage of cell death between pre (white bar) and post (black
bar) treatments.
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Figure 6: Percent of MCF-7 human breast cancer cells killed following 48 h treatment with plasma
from participant P11 that was isolated from blood drawn before (pre) and after (post) consumption
of red raspberries. Cells were plated in DMEM containing varying concentrations of the
participants’ pre and post plasma. Following 48 h incubation, cell viability was measured using the
MTS assay. *, P < 0.01 for differences in percentage of cell death for cells treated with participants
pre plasma (white bars) and post plasma (black bars).
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Figure 7: Percent of MCF-7 human breast cancer cells killed following 48 h treatment with plasma
from participant P02 that was isolated from blood drawn before (pre) and after (post) consumption
of red raspberries. Cells were plated in DMEM containing varying concentrations of the
participants’ pre and post plasma. Following 48 h incubation, cell viability was measured using the
MTS assay. *, P < 0.01 for differences in percentage of cell death for cells treated with participants
pre plasma (white bars) and post plasma (black bars).
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Figure 8: Percent of MCF-7 human breast cancer cells killed following 48 h treatment with plasma
from participant P01 that was isolated from blood drawn before (pre) and after (post) consumption
of red raspberries. Cells were plated in DMEM containing varying concentrations of the
participants’ pre and post plasma. Following 48 h incubation, cell viability was measured using the
MTS assay. *, P < 0.01 for differences in percentage of cell death for cells treated with participants
pre plasma (white bars) and post plasma (black bars).
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cytotoxic effect at the 5% plasma concentration while P11 showed a significant increase
at the 8% plasma concentration. For the plasma concentrations not showing a significant
increase in cytotoxicity, the amounts of cell death were comparable and there were no
significant decreases observed.
In order to detect other anticarcinogenic properties of red raspberry extract, three
cell lines were cultured for 48 h in the presence and absence of the extract and their
viabilities measured. The cell lines used were: MCF-7 (breast), AGS (stomach) and
LoVo (colon). Because berry extract is acidic, it was necessary to consider the role of pH
in cell killing. Each cell line was treated with solutions of HCl and ascorbic acid adjusted
to have the same pH as the berry extract. The HCl solution should serve as a control for
the pH effect alone, while ascorbic acid should also include an antioxidant effect in
killing. Results of these assays are shown in Figure 9-Figure 11 and Table 1. All three
cell lines were strongly inhibited by red raspberry extract with LoVo and AGS showing
the greatest sensitivity. For LoVo and AGS, red raspberry extract showed a significantly
higher level of inhibition than that observed for HCl or ascorbic acid. MCF-7 was also
strongly inhibited by red raspberry extract, but had a greater level of sensitivity to
ascorbic acid than did LoVo or AGS. There was no significant difference in cytoxocity
activity by red raspberry extract and ascorbic acid in the MCF-7 cell line. HCl treatment
had no effect on the survival of any of the cell lines.
To confirm the results of the MTS assays each cell line tested for viability by
trypan blue exclusion following 48 h treatment with red raspberry extract. For all three
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cell lines it was observed that untreated cells remained clear while treated cells were dark
blue, revealing that untreated cells excluded trypan blue while treated cells did not.
In order to determine whether caspase-induced apoptosis was induced by the red
raspberry extract, preliminary assays were done to assay for caspase activity. Activities
of caspases 3/7, 8, and 9 were assayed in AGS cells treated with red raspberry extract at
the same concentration as that used in the viability assays. Figure 12 shows the results of
these assays. There were no significant differences between the caspase activities
observed for the treated and untreated cells.
Since the preliminary data suggested that caspases were not being activated as a
result of red raspberry treatment and because further analysis of individual caspase
activity was not possible, each of the three cell lines used in the viability assays was
treated with red raspberry extract in the presence and absence of a pan-caspase inhibitor
(Z-VAD-FMK). The resulting percentages of cell death are shown in Figure 13. There
was no significant difference in cell death between those cells treated with red raspberry
extract in the presence of Z-VAD-FMK and those treated in the absence of Z-VAD-FMK
for any of the cell lines.
The antioxidant capacities of the raspberry extract and pH 3.3 ascorbic acid were
assayed in triplicate using the Total Antioxidant Status Assay Kit from Calbiochem®.
Antioxidants inhibit the oxidation of ABTS™ to ABTS™●+ by metmyoglobin. The
production of ABTS™●+ is indicated by the formation of a green color. Higher levels of
antioxidants will interfere with ABTS™●+ production and produce lower absorbance
values. Antioxidant concentrations in samples are calculated by comparing their

39

absorbance values to the absorbance values of a standard using the following formula:
([Standard] (∆A Blank – ∆A Sample))/(∆A Blank – ∆A Standard), where [Standard]
represents the concentration of the standard in mM units. In this assay the antioxidant
concentrations of ascorbic acid and raspberry extract were 1.86 mM and 1.45 mM,
respectively.
Confocal images of AGS cells treated with 10% red raspberry extract are
compared with untreated cells in Figures 14 and 15, respectively. DAPI stains dsDNA
and produces blue fluorescence while Texas Red®-X phalloidin stains F-actin and
produces red fluorescence. The chromatin and f-actin structures appear to be intact and
well-defined in the untreated cell shown in Figure 14. The treated cell shown in Figure
15 appears to show several holes formed in the f-actin structure as well as condensation
of the chromatin.
Figure 16 shows photomicrographs of AGS, LoVo and MCF-7 cells prior to
treatment (pretreatment) and following 48 h of treatment with 10% red raspberry extract
(treated) or non-treatment (untreated). No changes are observed between the
pretreatment and untreated cells. Treated cells, however, show some signs of plasma
membrane breakdown and chromatin condensation.
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Figure 9: Percent of AGS human stomach cancer cells killed following 48 h treatment with HCl,
ascorbic acid, or red raspberry extract. For each cell line, cells were treated prior to cell adhesion
and following cell adhesion. Cell viabilities were measured using the MTS assay. *, P < 0.05 for
differences in cell death between cells treated with red raspberry extract and cells treated with
ascorbic acid.
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Figure 10: Percent of LoVo human breast cancer cells killed following 48 h treatment with HCl,
ascorbic acid, or red raspberry extract. For each cell line, cells were treated prior to cell adhesion
and following cell adhesion. Cell viabilities were measured using the MTS assay. *, P < 0.05 for
differences in cell death between cells treated with red raspberry extract and cells treated with
ascorbic acid.

42

MCF7 Cell Death
100
80

% Cell Death

60
40
Adhered

20

Nonadhered
0
-20
-40
HCl

Ascorbic Acid

Raspberry Extract

Treatment

Figure 11: Percent of MCF-7 human breast cancer cells killed following 48 h treatment with HCl,
ascorbic acid, or red raspberry extract. For each cell line, cells were treated prior to cell adhesion
and following cell adhesion. Cell viabilities were measured using the MTS assay. No significant
difference was observed between the amounts of cell death induced by ascorbic acid and red
raspberry extract.

% Cell Death
AGS

LoVo

MCF-7

Adhered Nonadhered Adhered Nonadhered Adhered Nonadhered
Extract
Ascorbic
Acid
HCl

95.02

98.9

90.94

98.59

73.2

77.6

34.08

44.96

14.2

33.68

64.67

51.94

3.32

-0.06

0.53

2.96

-1.86

-18.27

Table 1: Percent of cell death in AGS human stomach, LoVo human colon and MCF-7 human breast
cancer cells following treatment with red raspberry extract, ascorbic acid or HCl. Each cell line was
treated for 48 h with 10% concentrations of red raspberry extract, ascorbic acid or HCl. Ascorbic
acid and HCl were both adjusted to a pH of 3.3 to match the pH of the red raspberry extract. For
each cell line, cells were treated when plated (nonadhered) as well as following adhesion (adhered).
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Figure 12: Activities of caspases 3/7, 8, and 9 in AGS human stomach cancer cells untreated (black
bar) and treated with 10% red raspberry extract (white bar). Following treatment, Caspase-Glo®
reagent was added to all wells. Caspase activity was measured as relative luminescence units (RLU)
using a Tecan plate-reading luminometer. No significant differences between the treated and
untreated cells were observed for any of the caspase activities.
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Figure 13: Percent of MCF-7 human breast cancer, LoVo human colon cancer, and AGS human
stomach cancer cells killed following treatment with 10% red raspberry extract in the presence
(black bar) or absence (white bar) of the pan-caspase inhibitor Z-VAD-FMK. Cells were plated and
treated for 48 h followed by measurement of cell viability using the MTS assay. No significant
difference in cell death was observed between cells incubated in the presence presence or absence of
Z-VAD-FMK for any of the cell lines.
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Figure 14:: Confocal image of AGS cell treated with 10% red
raspberry extract showing dsDNA stained with DAPI and
F-actin stained with Texas Red®-X
X phalloidin. Following
fixation, the cells were stained with DAPI and Texas Red®
Red®-X
phalloidin and dehydrated in a graded ethanol series. Slides
were viewed using a Nikon™ Eclipse Ti confocal microscope
microscope.
DAPI was excited with a 405 nm laser coupled to a 488 nm
detector. Texas Red®-X phalloidin was excited with a 543 nm
laser coupled to a 605 nm detector. Here the chromatin and
f-actin structures appear intact and well-defined.
defined.

Figure 15: Confocal image of untreated AGS cell showing
dsDNA stained with DAPI and F-actin
actin stained with Texas
Red®
Red®-X
X phalloidin. Following fixation, the cells were stained
with DAP and Texas Red®-X
X phalloidin and dehydrated in a
graded ethano
ethanoll series. Slides were viewed using a Nikon™
Eclipse Ti confocal microscope. DAPI was excited with a 405
nm laser coupled to a 488 nm detector. Texas Red®-X
Red®
phalloidin was excited with a 543 nm laser coupled to a 605 nm
detector. In contrast to the untreated cell sshown in Figure 14,
the f-actin
tin structure appears to show several holes and the
chromatin appears to be undergoing condensation.
condensa
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Figure 16: Photomicrographs of AGS human stomach cancer, LoVo human colon cancer and MCF
MCF-7 human breast
cancer cell lines showing effects of 48 h treatment with 10% red raspberry extract. Untreated cells show no obvious
difference from the pretreatment. Treated cells show changes in the cell morphology, including membrane breakdown
and early signs of chromatin condensation.
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4. DISCUSSION
The results presented here indicate that red raspberries can inhibit the
development or growth of cancer by two mechanisms. We have demonstrated in this
study that, for some individuals, the consumption of red raspberries enhances the
cytotoxic activity of NK cells. Also, data from three individuals suggests that
consumption of red raspberries leads to production of blood plasma components, such as
ellagic acid, which are toxic to cancer cells in vitro. Additionally, we show that an
aqueous extract from red raspberries has a potent cytotoxic effect on the AGS and LoVo
cell lines that cannot be attributed to its antioxidant capacity or to changes in pH. MCF-7
cells treated with the extract were also killed efficiently, but cell death was not
significantly higher than cells treated with an ascorbic acid antioxidant control. Because
cell death in all three cell lines was not affected by the presence of a caspase inhibitor, it
was determined that caspase-dependent apoptosis was not being activated by the extract.
AGS cells treated with extract and then prepared for confocal imaging yielded little
information on the mechanism of cell death being activated. Staining for double-stranded
DNA and F-actin showed few differences between untreated cells and cells treated with
extract. Confocal images of the treated AGS cells showed some breakdown in the Factin structure and possible chromatin condensation. Photomicrographs of treated and
untreated cells revealed that untreated cells showed no obvious changes when compared
to the pretreatment. Treated cells however were visibly different, with an apparent
breakdown in the plasma membrane and signs of chromatin condensation. Further, when
treated and untreated cells were treated with trypsin and analyzed by trypan blue
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exclusion, it was observed that untreated cells remained intact and viable while no intact
cells were observed from the treated cells.
The current study was undertaken in order to address the lack of data explaining
the decreased risk of developing cancer resulting from fruit and vegetable consumption.
It is now a commonly accepted belief that increased consumption of fruits and vegetables
correlates to a decreased risk for developing various diseases, including cancer. This
conclusion is primarily based on the large body of epidemiological evidence that has
accumulated over the years. Based on the evidence from epidemiological studies, the
American Cancer Society now recommends five servings of a variety of fruits and
vegetables daily (Kushi et al., 2006). According to a report from a 1997 joint conference
between the American Institute for Cancer Research and the World Cancer Research
Fund, following this recommendation could result in the prevention of at least 20% of all
cancers (Glade, 1999).
While epidemiology shows a strong inverse relationship between fruit and
vegetable consumption and risk for developing cancer, there is little laboratory evidence
explaining the biological bases for this decreased risk. Many in vitro studies have been
done to test natural products for anticarcinogenic properties. While it is broadly assumed
that mechanisms observed in the in vitro results are responsible for the decreased cancer
risk observed in epidemiological studies, there are many factors that cloud the picture,
including immunological effects, metabolic changes in the components of the fruits, and
the genetic differences among people. By doing this study, we sought to gain some
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insight into the positive physiological effects resulting from consumption of red
raspberries that could be a factor in reducing cancer risk.
Red raspberries have been evaluated in numerous studies for their content of
phytochemicals which could contribute to positive health benefits. Mullen et al. (2002)
identified as many as 11 different anthocyanins in raspberries and concluded that
ellagitannins contribute significantly to their antioxidant and vasodilation properties. The
same study also identified three quercetin conjugates and vitamin C in raspberries.
However, it is suspected that vitamin C and the anthocyanins play a minor role in the
antioxidant capacity of raspberries. As evidence for this, Kalt et al. (1999) determined
that vitamin C is responsible for only 6% of the antioxidant activity of certain raspberries.
By contrast, Anttonen and Karjalainen (2005) showed the ellagitannin sanguiin H-6
accounts for over 30% of the antioxidant activity of red raspberries. Ellagitannin content
is significant because, when metabolized, ellagitannins release ellagic acid (Mullen et al.,
2002). In vitro studies on ellagic acid have shown a protective effect against colon, lung,
esophageal, bladder, and pancreatic cancers (Stoner and Morse, 1997; Narayanan and Re,
2001; Li et al., 2005; Edderkaoui et al., 2008). Narayanan and Re (2001) demonstrated
that SW-480 human colon cancer cells, when treated with ellagic acid, showed down
regulation of insulin like growth factor IGF-II and activation of p21, resulting in
apoptotic death. Edderkaoui et al., (2008) showed that ellagic treatment of human
pancreatic cancer cell lines (MIA PaCa-2 and PANK-1) resulted in inhibition of nuclear
factor κB (NF-κB) resulting in apoptosis. It seems apparent from these analyses that red
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raspberries do indeed contain significant levels of phytochemicals with the potential to
impart positive health benefits when consumed.
While it is clear that the phytochemicals in red raspberries have properties which,
when tested in vitro, show that the berries should have anticarcinogenic properties, it has
not been determined how these observations apply to the in vivo situation. It is not clear
if consumption of red raspberries produces the same anticancer effects. In the present
study we show that the plasma taken from three individuals following their consumption
of red raspberries causes a significant decrease in the survival of the MCF-7 breast cancer
cell line when compared to plasma taken from the same individuals prior to their
consumption of the berries. While further work on a larger number of individuals is
required, these results show that consumption of red raspberries does indeed lead to the
accumulation of compounds in the plasma which have the potential to exert an anticancer
effect, possibly inducing apoptosis in transformed cells through the mechanisms
described above by Narayanan and Re (2001) and Edderkaoui et al., (2008) for ellagic
acid, an important component of red raspberries.
Natural killer cells are an important component of innate immunity, involved in
the destruction of transformed and virally infected cells and the production of various
cytokines, primarily IFN-γ. They elicit their cytotoxic effects through mechanisms that
mirror those of cytotoxic T cells. The primary method employed by NK cells to induce
cytotoxicity involves the release of cytotoxic granules, perforin and granzyme. Upon
contact with a target cell that results in their activation, NK cells release perforin and
granzyme and these work together to activate caspases in the target cell, leading to
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apoptosis. If caspase-dependent apoptosis is blocked, granzymes may alternatively turn
on caspase-independent apoptosis by mediating the release of cytochrome C from the
mitochondria or through granzyme A activation of the DNase NM23-HI (Cullen and
Martin, 2008). In addition to the perforin/granzyme pathway, NK cells share the TRAIL
and FasL pathways of cell death. Upon binding to their respective receptors on target
cells, TRAIL and FasL activate pro-caspase-8, leading to caspase-dependent apoptosis.
The importance of NK cells in cancer prevention is illustrated in studies which
show that decreased NK cytotoxicity correlates to an increased risk for developing cancer
and which also show that NK cytotoxicity is diminished in individuals with cancer
(Wustrow and Zenner, 1985; Imai et al., 2000; Dewan et al., 2009). Further evidence for
the role of NK cells in preventing cancer is gleaned from a study by Kim et al. (2000)
which found that when mice were i.v. inoculated with the highly metastatic subline of
murine B16 melanoma, B16BL6, they developed significantly fewer metases if treated
with a NK activating molecule. Numerous studies have also revealed that NK cells are
not only important in preventing cancer, but also in the control of established tumors.
Tumor infiltration by NK cells correlates to a positive prognosis and this effect has been
shown for pulmonary adenocarcinoma, squamous cell carcinoma, colorectal carcinoma,
gastric carcinoma and lung cancer (Coca et al., 2007; Ishigami et al., 2000; Takanami et
al., 2001; Suminami et al., 2001; Villegas et al., 2002).
In our study, 5/15 (33%) volunteers demonstrated a significantly higher level of
NK cytotoxicity towards K-562 target cells following consumption of red raspberries for
a 4 day period. This study is one of the first of its kind and has laid the groundwork for
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future investigations. While the concept for the assay was adopted from Heo et al. (1990)
it was necessary to make modifications as the study progressed. The most notable
change was the switch from using MCF-7 cells as targets to the use of the K-562 cell line
which is the standard cell line used in NK cytotoxicity studies. Another significant
modification was the use of Dynabeads® CD14 magnetic beads to deplete monocytes
from the PBMNCs. Prior to the use of the CD14 magnetic beads, monocytes were
depleted by incubating the PBMNCs in a plastic Petri dish for 1 hr at 37°C. The results
from this approach seemed to be inconsistent, leading to the switch to CD14 magnetic
bead depletion. Other changes made include adjustments to volumes and cell
concentrations added to wells in order to achieve absorbances in the reliable range.
Altogether, these changes served to produce an assay which can be reliably used in future
studies.
Among the components of fruits and vegetables are the antioxidants, which are
thought to play a role physiologically in scavenging free radicals. Free radicals are
generated through normal cellular metabolism and through environmental factors. Left
unchecked, these free radicals cause damage to various cellular components, including
DNA, which could lead to the formation of a transformed cell. Liu et al. (2002)
evaluated the antioxidant and antiproliferative activities of four varieties of raspberries.
While the Meeker variety was not one of the varieties they tested, their results showed a
significant antiproliferative effect for all four extracts against the HepG2 human liver cell
line. This study did not, however, correlate the levels of antioxidant activities for each of
the four varieties to their antiproliferative effects. Nor did they explore the mechanism of
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the antiproliferative effect. Our results demonstrated that the Meeker variety of red
raspberry has a potent cytotoxic effect on AGS, LoVo and MCF-7 cells. Further, by
comparison to an ascorbic acid control, we demonstrate that a significant percentage of
Meeker extract’s cytotoxic effect on the AGS and LoVo cell lines is clearly attributable
to factors other than the antioxidant effect. At the 10% concentration used in the viability
assays, the Meeker extract showed a significantly higher level of cytotoxic activity
towards AGS and LoVo cells than did ascorbic acid of the same pH. At the same
concentrations, the Meeker extract also demonstrated lower antioxidant activity than did
ascorbic acid.
McDougall et al. (2008) showed a strong antiproliferative effect for raspberry
extract towards the HeLa human cervical cancer and CaCo-2 human colon cancer cell
lines, but the variety of raspberry tested was not specified and the mechanism of the
antiproliferative effect was not identified. Previous studies in our lab have shown that
different varieties of the same berry can vary with respect to results achieved in in vitro
assays measuring anticarcinogenic potential. In another study, Seeram et al. (2006)
tested several types of berries, including red raspberries, and determined that they were
capable of inducing apoptosis in the HT-29 human colon cancer cell line. Red
raspberries showed an 80% increase in apoptosis in comparison to untreated controls. As
in the study by McDougall et al. (2008), Seeram et al. (2006) did not specify the variety
of red raspberry used in their assays.
Our microscopic observations of morphological changes in the AGS, LoVo and
MCF-7 treated with red raspberry extract did not provide definitive evidence of any
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mechanism of cell death. No membrane blebbing was observed and cells appeared to
remain firmly attached. There did appear to be some breakdown of the plasma
membrane and signs of early chromatin condensation. Additionally, when cells were
examined for trypan blue exclusion following 48 h treatment with red raspberry extract, it
was observed that untreated cells excluded trypan blue while treated cells did not. This
provides solid evidence that the extract is indeed killing the cells, but does not distinguish
between apoptosis or necrosis. Confocal imaging of the treated AGS cells also did not
reveal any definitive changes that pointed to a specific type of cell death. AGS cells that
had been treated with extract and stained with DAPI and Texas Red Phalloidin did show
breakdown in the F-actin structure and possible chromatin condensation.
Further, assays measuring the activities of Caspases 3/7, 8 and 9 showed no
significant increases in caspase activity in AGS cells treated with extract relative to
untreated cells. Also, there was no significant change in cell death observed between
cells treated with extract in the presence or absence of a caspase inhibitor. Based on
these observations, it does not appear that Meeker red raspberry extracts is inducing
apoptosis in the AGS cells. Thus, our results do not agree with those obtained by Seeram
et al. (2006).
Apoptosis is a mechanism of cell death whereby the cell fragments into small
self-contained pieces by membrane blebbing. As membrane blebbing occurs,
macrophages are involved in phagocytosis and breakdown of the cellular fragments.
Thus, the cellular contents are largely contained and the inflammatory reactions
associated with necrotic cell death are avoided. There are several other mechanisms of
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cell death, including autophagy and mitotic catastrophe, and further work needs to be
carried out to determine the type of cell death, if any, being induced by Meeker red
raspberries.
In conclusion, the results reported in this study show that consumption of red
raspberries increases the cytotoxic activity of NK cells in some individuals. Due to their
importance in the control of transformed cells, any factors that enhance NK function
could prove valuable in the search for effective means of preventing cancer. We also
show that consumption of red raspberries increases the cytotoxic effect of plasma towards
cancer cells. The combined effects of increased NK cytotoxicity and increased cytotoxic
activity of plasma towards cancer cells may provide a potent mechanism for cancer
prevention. Finally, our results demonstrate that red raspberry extract has a direct
cytotoxic effect on cancer cells and this cytotoxic effect cannot be attributed solely to
changes in pH or antioxidant concentrations.
We believe the results obtained in this study warrant further exploration into the
physiological changes that result from consumption of fruits and vegetables. This an area
of research that has much promise, but which has gone largely unexplored. As our
research continues, it will be necessary to test a larger population of individuals for
increased NK cytotoxicity. If this effect can be shown, then determining mechanisms
underlying the increase in NK cytotoxicity will become an important focus of the
research. Additionally, the effect of donor plasma on cancer cells needs to be evaluated
for all study participants. Other avenues for expanding the research include testing the
cytotoxic activity of the whole PBMNC as opposed to the PBL and having participants
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consume a combination of berries. Some studies have suggested that optimal health
benefits are achieved when a variety of fruits and vegetables are consumed, so having
participants consume a combination of different berries may be an area of research
worthy investigating.
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APPENDIX
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Figure A1: Percent of MCF-7 target cells killed by treatment with peripheral blood lymphocytes
(PBL) isolated from P01 before and after consumption of red raspberries. MCF-7 and PBL were
incubated together for 4 h. This was followed by a measurement of cell viability using the MTS
assay.
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Figure A2: Percent of MCF-7 target cells killed by treatment with peripheral blood lymphocytes
(PBL) isolated from P02 before and after consumption of red raspberries. MCF-7 and PBL were
incubated together for 4 h. This was followed by a measurement of cell viability using the MTS
assay.
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Figure A3: Percent of MCF-7 target cells killed by treatment with peripheral blood lymphocytes
(PBL) isolated from P03 before and after consumption of red raspberries. MCF-7 and PBL were
incubated together for 4 h. This was followed by a measurement of cell viability using the MTS
assay.
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Figure A4: Percent of MCF-7 target cells killed by treatment with peripheral blood lymphocytes
(PBL) isolated from P04 before and after consumption of red raspberries. MCF-7 and PBL were
incubated together for 4 h. This was followed by a measurement of cell viability using the MTS
assay.
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Figure A5: Percent of MCF-7 target cells killed by treatment with peripheral blood lymphocytes
(PBL) isolated from P05 before and after consumption of red raspberries. MCF-7 and PBL were
incubated together for 4 h. This was followed by a measurement of cell viability using the MTS
assay.
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Figure A6: Percent of MCF-7 target cells killed by treatment with peripheral blood lymphocytes
(PBL) isolated from P06 before and after consumption of red raspberries. MCF-7 and PBL were
incubated together for 4 h. This was followed by a measurement of cell viability using the MTS
assay.

60

% Cell Death

P07 NK Cytotoxicity
25
20
15
10
5
0
-5
-10
-15
-20
-25

Pre
Post

1.25:1

2.5:1

5:1

10:1

Effector:Target

Figure A7: Percent of MCF-7 target cells killed by treatment with peripheral blood lymphocytes
(PBL) isolated from P07 before and after consumption of red raspberries. MCF-7 and PBL were
incubated together for 4 h. This was followed by a measurement of cell viability using the MTS
assay.
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Figure A8: Percent of MCF-7 target cells killed by treatment with peripheral blood lymphocytes
(PBL) isolated from P08 before and after consumption of red raspberries. MCF-7 and PBL were
incubated together for 4 h. This was followed by a measurement of cell viability using the MTS
assay.
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Figure A9: Percent of K-562 target cells killed by treatment with peripheral blood lymphocytes
(PBL) isolated from P003 before and after consumption of red raspberries. K-562 and PBL were
incubated together for 4 h. This was followed by a measurement of cell viability using the MTS
assay.
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Figure A10: Percent of K-562 target cells killed by treatment with peripheral blood lymphocytes
(PBL) isolated from P01 before and after consumption of red raspberries. K-562 and PBL were
incubated together for 4 h. This was followed by a measurement of cell viability using the MTS
assay.
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